The risk of cardiovascular disease (CVD) is associated with unusual changes in the human gut microbiota, most commonly coronary atherosclerotic heart disease, hypertension, and heart failure. Immune mechanisms maintain a dynamic balance between the gut microbiota and the host immune system. When one side changes and the balance is disrupted, different degrees of damage are inflicted on the host and a diseased state gradually develops over time. This review summarizes the immune mechanism of the gut microbiota and its metabolites in the occurrence of common CVDs, discusses the relationship between gut-heart axis dysfunction and the progression of CVD, and lists the currently effective methods of regulating the gut microbiota for the treatment of CVDs.
CITATION STYLE
Lu, J., Jin, X., Yang, S., Li, Y., Wang, X., & Wu, M. (2022, December 14). Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2022.1034537
Mendeley helps you to discover research relevant for your work.